2019 CYIR Finalized
8 EARLY STAGE LUNG CANCER TREATMENT Cykert S, Eng E, Walker P, Manning MA, Roberston LB, Arya R, Jones NS, Heron DE. A system-based interven- tion to reduce Black-White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers. Cancer Med. Feb 2019. DOI: 10.1002/ cam4.2005 Summary For the majority of patients, surgical lung resection is the guideline recommendation for cure of early stage, non- small cell lung cancer. Despite this recommendation, Black patients undergo surgery less often that similarly-matched White patients. This disparity goes beyond socioeco- nomic status, age, and co-morbid conditions. To address this disparity, authors worked with community partners to develop a multifaceted intervention that included real- time audit, race-specific accountability, and enhanced, patient-centered communication through the electronic medical record. Using a pragmatic trial design, authors prospectively enrolled 360 (32% Black) patients aged 18-85 years, diagnosed with Stage I or II lung cancer, and receiving care at one of 5 cancer centers. These patients were compared to a retrospective cohort (n=2841, 16% Black) of early stage lung cancer patients from the same centers. In this retrospective cohort group, 78% of White patients underwent surgical resection compared with 69% of the Black group. After intervention, 96% of all patients enrolled underwent surgical resection, closing the dispar- ity gap and increasing treatment in both Black and White patients. By using a pragmatic study design, the study also demonstrates the feasibility of incorporating the interven- tion across several medical systems. Comments 1. This is one of few studies that have evaluated a multi-com- ponent intervention to address the Black-White treatment for non-small cell lung cancer. 2. Authors aim to close the Black-White treatment gap for non- small cell lung cancer with an innovative intervention design developed in conjunction with community partners. 3. The multi-faceted intervention not only closed the Black-White treatment gap, but also improved rates of surgical resection across all groups. 4. Limitations include using a retrospective cohort as a control group where secular trends may impact results; however, authors were able to determine that findings were above what would be expected for secular trend. 5. One major strength is the trials pragmatic design, demonstrat- ing feasibility of intervention across multiple medical systems. SOCIOECONOMIC STATUS, IDIOPATHIC PULMONARY FIBROSIS, AND LUNG TRANSPLANT TREATMENT Gaffney AW, Woolhander S, Himmelstein D, McCormick D. Disparities in pulmonary fibrosis care in the United States: an analysis from the Nationwide Inpatient Sample. BMC Health Services Research. 2018; 18: 618 Summary Previous studies have demonstrated that individuals of low socioeconomic status (SES) undergo INTERVENTIONAL PULMONOLOGY less often compared with their higher SES counterparts. Using hospital admission data from the Nationwide Inpatient Sample (NWIS), authors exam- ined whether socioeconomic status, defined by insurance status and zip-code level income, was associated with differences in INTERVENTIONAL PULMONOLOGY and mortality among hospitalized adults with idiopathic pul- monary fibrosis. Patients with no insurance or Medicaid insurance were younger, had fewer co-morbid conditions and were hospitalized with less severe disease compared with those with non-Medicaid insurance. Across all admis- sions with idiopathic pulmonary fibrosis as a primary or secondary diagnosis code, patients with no insurance or Medicaid insurance were significantly less likely to undergo lung transplant compared with patients with non-Medicaid (private or Medicare) insurance, even after adjusting for age, co-morbid conditions, and disease severity. Similarly, patients in the lower three quartiles of median ZIP code income were less likely to receive a transplant than those in the higher quartile. These findings remained true in a sensi- tivity analysis limited to patients less than 65 years of age. This study demonstrates the inequity in transplant access but needs to be interpreted with caution as results reflect hospital admissions and not individuals. Comments 1. Compared with patients with Medicare or private insurance, patients with no insurance or Medicaid insurance were less likely to undergo INTERVENTIONAL PULMONOLOGY for idio- pathic pulmonary fibrosis. 2. Patients from the lowest three quartiles of ZIP-code level incomes were also less likely to receive lung transplant com- pared with those in the highest quartile. SUNDAY, MAY 19 HEALTH DISPARITIES Neeta Thakur, MD, MPH University of California, San Francisco San Francisco, CA HEALTH DISPARITIES
Made with FlippingBook
RkJQdWJsaXNoZXIy MTM1ODMw